The WACC of Egetis Therapeutics AB (publ) (EGTX.ST) is 6.2%.
| Range | Selected | |
| Cost of equity | 5.00% - 7.40% | 6.20% |
| Tax rate | 20.60% - 20.90% | 20.75% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 5.0% - 7.3% | 6.2% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.39 | 0.55 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 5.00% | 7.40% |
| Tax rate | 20.60% | 20.90% |
| Debt/Equity ratio | 0.05 | 0.05 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 5.0% | 7.3% |
| Selected WACC | 6.2% | |